- Home
- LPSN vs GNTA Comparison
LPSN vs GNTA Comparison
Compare LPSN & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- GNTA
- Stock Information
- Founded
- LPSN 1995
- GNTA 2014
- Country
- LPSN United States
- GNTA Italy
- Employees
- LPSN N/A
- GNTA N/A
- Industry
- LPSN EDP Services
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LPSN Technology
- GNTA Health Care
- Exchange
- LPSN Nasdaq
- GNTA Nasdaq
- Market Cap
- LPSN 72.8M
- GNTA 81.2M
- IPO Year
- LPSN 2000
- GNTA 2021
- Fundamental
- Price
- LPSN $0.99
- GNTA $3.11
- Analyst Decision
- LPSN Hold
- GNTA Strong Buy
- Analyst Count
- LPSN 3
- GNTA 1
- Target Price
- LPSN $1.20
- GNTA $25.00
- AVG Volume (30 Days)
- LPSN 1.2M
- GNTA 27.2K
- Earning Date
- LPSN 07-30-2025
- GNTA 01-01-0001
- Dividend Yield
- LPSN N/A
- GNTA N/A
- EPS Growth
- LPSN N/A
- GNTA N/A
- EPS
- LPSN N/A
- GNTA N/A
- Revenue
- LPSN $292,025,000.00
- GNTA N/A
- Revenue This Year
- LPSN N/A
- GNTA N/A
- Revenue Next Year
- LPSN $0.82
- GNTA N/A
- P/E Ratio
- LPSN N/A
- GNTA N/A
- Revenue Growth
- LPSN N/A
- GNTA N/A
- 52 Week Low
- LPSN $0.57
- GNTA $2.74
- 52 Week High
- LPSN $2.08
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- LPSN 66.22
- GNTA 22.05
- Support Level
- LPSN $0.88
- GNTA $2.90
- Resistance Level
- LPSN $1.04
- GNTA $3.29
- Average True Range (ATR)
- LPSN 0.07
- GNTA 0.18
- MACD
- LPSN 0.03
- GNTA -0.05
- Stochastic Oscillator
- LPSN 83.58
- GNTA 9.02
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.